You are here:Home-Experts-Anders Karlén

Anders Karlén

Anders Karlén is a professor of Computer-Aided Drug Design at Uppsala University and focuses on hit identification and lead development in antibacterial drug discovery.

His research group studies targets of importance in infectious diseases with a focus on tuberculosis and Gram-negative infections. At Uppsala University, he is the overall medicinal chemistry project leader for drug discovery efforts directed at several different anti-bacterial targets.

Since February 2014, Anders has led the Managing Entity as well as been co-coordinator of the project from the Innovative Medicines Initiative (IMI) entitled European Gram-negative Antibacterial Engine (ENABLE). Since 2019, Anders has also coordinated the project within IMI’s Antimicrobial Resistance (AMR) Accelerator Programme entitled Collaboration for Prevention and Treatment of MDR Bacterial Infections (COMBINE).

2020-05-28T13:43:42+00:00